Market News: South Korea's National Power Party discusses Yin Xiyue's stepping down in February or March.The trio set up a new digital technology company in Horgos, and the enterprise search APP shows that Horgos moderns Digital Technology Co., Ltd. was recently established, with Ye Gengen as the legal representative and a registered capital of 10 million yuan. Its business scope includes: digital creative product exhibition service; Data processing and storage support services, etc. Enterprise investigation shows that the company is wholly owned by three banks.Murdoch's request to modify the control of the family trust was reportedly rejected. According to people familiar with the matter, a probate commissioner in Nevada rejected a request by Rupert Murdoch to hand over the control of his media assets to his eldest son after his death, instead of dividing it equally among his four children. Murdoch, 93, had previously tried to modify a trust holding his family assets, including about 40% voting shares of Flowserve and News Corporation.
Yonhap News Agency: Kim Sang-wook, a member of South Korea's ruling party, expressed his support for impeaching President Yin Xiyue.General Administration of Customs: Import and export of general trade and processing trade increased. According to customs statistics, in the first 11 months, China's general trade import and export was 25.5 trillion yuan, an increase of 3.7%, accounting for 64.1% of China's total foreign trade. Among them, the export was 15.04 trillion yuan, up by 7.9%; Imports reached 10.46 trillion yuan, down 1.8%. In the same period, the import and export of processing trade was 7.22 trillion yuan, up by 3.6%, accounting for 18.1%. Among them, exports were 4.58 trillion yuan, an increase of 1.8%; Imports reached 2.64 trillion yuan, up 6.9%. In addition, China's import and export by bonded logistics was 5.64 trillion yuan, an increase of 13%. Among them, exports were 2.2 trillion yuan, an increase of 10.9%; Imports reached 3.44 trillion yuan, up by 14.4%.
Xinjiang's revitalization plate rose in a short period of time, Xinjiang Jiaojian had a daily limit, Qingsong Jianhua, Bona Film and Friendship Group had previously closed the board, the western animal husbandry rose by more than 10%, and the western construction, Beixin Road and Bridge, Tianshun shares, Beiken Energy and Guotong shares followed suit.Russian diplomat: The Security Council will release documents related to Syria in the "next few days". According to a report by the Russian satellite agency on December 10, Russian Permanent Representative to the United Nations Vasily Niebianjia said on December 9 that members of the UN Security Council discussed the necessity of formulating a document related to the situation in Syria in closed-door consultations on December 9, which may be released in the next few days. According to the report, Nie Bianjia pointed out: "We discussed the necessity of the Security Council to formulate a document. No one is ready today, but I think we will see it in the next few days, and hope that the sooner the better. " Commenting on the fate of Russian troops staying in Syria after the regime change in Syria, Niebianjia added that this question was asked to the wrong person. Nie Bianjia said in response to a reporter's question on this topic: "You asked the wrong person." (Reference message)Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.
Strategy guide
Strategy guide
12-13
Strategy guide
12-13